Risk for nonscarring hair loss increased in association with GLP-1 receptor agonist use

The risk for nonscarring hair loss (NSHL) is increased in association with glucagon-like peptide-1 receptor agonist (GLP-1 RA) use, according to a study published online Feb. 9 in the Journal of the American Academy of Dermatology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup